The NanoAssemblr®️ Spark™️ | Robust Low Volume RNA-Lipid Nanoparticle Formulation
Vložit
- čas přidán 15. 03. 2022
- Develop RNA-lipid nanoparticles (LNPs) in under 10 seconds for drug discovery and early preclinical development. The NanoAssemblr®️ Spark™️ instrument enables rapid µL formulations to conserve limited and expensive ingredients with minimal waste. The proprietary NxGen™️ microfluidic technology enables controlled and reproducible manufacturing of homogenous LNPs.
Learn more about the system: www.precisionn...
Follow us on LinkedIn: bit.ly/3F9uEiL
Follow us on Twitter: bit.ly/3yBttpW - Věda a technologie